Related StoriesDiabetic retinopathy therapy innovations: an interview with Richard Kirk.

Drug and Food Administration also granted Zoenasa orphan designation for the treating pediatric ulcerative colitis.. Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis Altheus Therapeutics, Inc. ‘We look forward to attaining alignment on our registration plan with the FDA and additional Health Authorities as the next phase to making Zoenasa available to IBD individuals.’ Related StoriesDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of PolyphotonixLenvatinib trial offers hope for thyroid malignancy patientsAlport syndrome: an interview with Dr Paul Grint, CMO, Regulus Nearly 1.2 million Americans have problems with inflammatory bowel disease.This is actually the third calendar year the consensus-based, multi-stakeholder business provided this unique recognition to top health care suppliers administrating Medicare prescription providers across the nation.

Bevacizumab offers no advantage for patients newly identified as having glioblastoma University of Maryland College of Medication radiation oncologist is senior writer of brain cancer research Adding bevacizumab to regular chemotherapy and radiation treatment will not improve survival for sufferers newly identified as having the often deadly human brain cancer glioblastoma, researchers survey in the Feb.